release one major TV ad, costs about $5-10 million, 4 weeks later they get about 225,000 scripts. Multiply that by $2000-3,000 per prescription, $500,000,000 in revenue. Not a bad return!
their morale is all time low and they are caving, something is gonna give and this will fly.
a little bird told me, SNY is buying mnkd after their trial run with AFrezza. ONLY a group of docs have been prescribing AFrezza. The rest of the half million docs can prescribe but if they don't know Afrezza, they can't prescribe.
Good entry here. Go inhale insuline and inhale whatever they can imagine after.
the trades seem to suggest they are fighting tooth and nail to find shares. Still alot of manipulations. But you are right, no urgency yet; also no shares to buy.
congrats to longs. I was hoping this would go the distance. But I will take a 5 bagger.